0000000000249575

AUTHOR

Marina Garriga

0000-0001-7312-4969

showing 6 related works from this author

Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Resul…

2017

Patients with bipolar disorder (BD) do not always achieve full remission between episodes. Subthreshold symptoms (depressive, manic or mixed) represent a major cause of relapse and disability in these patients. Immediate release (IR) and extended release (XR) formulations of quetiapine are both indicated for short and long-term treatment of BD. The aim of this study was to evaluate the efficacy of quetiapine XR vs placebo in subthreshold symptomatology when added to previous mood stabilizer treatment. A pilot phase IIIB, multicentre, prospective, placebo controlled, randomized, double blinded study of 12 weeks follow-up was performed (NCT01197846). Patients were randomized to quetiapine XR …

MaleBipolar Disorder*Bipolar disorderPilot Projectslaw.invention0302 clinical medicineRandomized controlled triallawAntimanic AgentsAmbulatory CarePharmacology (medical)*QuetiapineMood stabilizerMiddle AgedSubthreshold symptomsPsychiatry and Mental healthTreatment OutcomeNeurologyDrug Therapy CombinationFemalemedicine.symptomPsychologySomnolencemedicine.drugAdultmedicine.medical_specialtyAdolescentmedicine.drug_classBipolar disorderPlacebo03 medical and health sciencesQuetiapine FumarateYoung AdultDouble-Blind MethodInternal medicinemedicineHumans*Subthreshold symptomsBipolar disorderPsychiatryAdverse effectBiological PsychiatryAgedPharmacologyPsychiatric Status Rating ScalesQuetiapineBody Weightmedicine.disease030227 psychiatryMoodDelayed-Action PreparationsQuetiapineNeurology (clinical)030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Differential serum acute-phase biomarker profile in schizophrenia and bipolar disorder

2016

There is a growing interest in inflammation and immune dysfunction in severe psychiatric disorders such as schizophrenia and bipolar disorder. This dysfunction seems to consist in abnormal blood levels of cytokines and acute-phase proteins, with increased levels of C-reactive protein (CRP), fibrinogen, homocysteine and erythrocyte sedimentation rate (ESR). Higher levels can be found in acute episodes and in patients with a higher cardiovascular risk.Acute-phase protein serum parameters were determined in a sample of 100 outpatients with schizophrenia (n = 50) or bipolar disorder (n = 50) so as to assess differences in pro-inflammatory state. Metabolic state was assessed through BMI, waist c…

medicine.medical_specialtyHomocysteinemedicine.diagnostic_testTriglycerideCholesterolmedicine.diseaseFibrinogenPsychiatry and Mental healthchemistry.chemical_compoundEndocrinologychemistrySchizophreniaInternal medicineErythrocyte sedimentation ratemedicineBiomarker (medicine)Bipolar disorderPsychologymedicine.drugEuropean Psychiatry
researchProduct

Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.

2018

Background: Cognitive and psychosocial impairment has been associated with increased levels of C-reactive protein (CRP) and homocysteine in bipolar disorder, but gender differences have seldom been studied. Methods: Two hundred and twenty-four bipolar outpatients were included. Cognitive performance was assessed through the Screen for Cognitive Impairment in Psychiatry (SCIP). Psychosocial functioning was evaluated using the Functioning Assessment Short Test (FAST) and the General Assessment of Functioning (GAF). Homocysteine and CRP levels were determined. Separate analyses were performed by gender. Partial correlations were calculated to test for associations between biomarkers and cognit…

AdultMaleBipolar DisorderHomocysteineNeuropsychological TestsVerbal learning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCognitionSex FactorsmedicineRaw scoreVerbal fluency testHumansCognitive DysfunctionEffects of sleep deprivation on cognitive performanceBipolar disorderProspective StudiesHomocysteinebusiness.industryCognitionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthClinical PsychologyC-Reactive ProteinchemistryFemalebusinessPsychosocial030217 neurology & neurosurgeryClinical psychologyFollow-Up StudiesJournal of affective disorders
researchProduct

Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bip…

2022

OBJECTIVES Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and C-Reactive Protein (CRP) are markers of inflammation that are elevated in bipolar disorder (BD) and are also related to a higher risk of metabolic syndrome (MetS). This study aimed at investigating for the first time the association between NLR, PLR, and CRP and the metabolic status in BD. METHODS We assessed the association between biomarkers and the metabolic status: number of metabolic risk factors, presence of MetS, insulin sensitivity (Quantitative Insulin Sensitivity Check Index, QUICKI) and insulin resistance (Homeostatic Model Assessment for Insulin Resistance, HOMA-IR index), in a sample of 219 outpa…

medicine.medical_specialtyBipolar DisorderNeutrophilsLymphocyteInflammationGastroenterologyInsulin resistanceInternal medicinemedicineHumansLymphocytesBipolar disorderBiological PsychiatryRetrospective StudiesMetabolic SyndromebiologyPlatelet Countbusiness.industryC-reactive proteinQuantitative insulin sensitivity check indexmedicine.diseasePsychiatry and Mental healthC-Reactive Proteinmedicine.anatomical_structurebiology.proteinHomeostatic model assessmentInsulin ResistanceMetabolic syndromemedicine.symptombusinessBiomarkersThe World Journal of Biological Psychiatry
researchProduct

Assessment and management of agitation in psychiatry: Expert consensus

2016

International audience; BACKGROUND:Psychomotor agitation is associated with different psychiatric conditions and represents an important issue in psychiatry. Current recommendations on agitation in psychiatry are not univocal. Actually, an improper assessment and management may result in unnecessary coercive or sedative treatments. A thorough and balanced review plus an expert consensus can guide assessment and treatment decisions.METHODS:An expert task force iteratively developed consensus using the Delphi method. Initial survey items were based on systematic review of the literature. Subsequent surveys included new, re-worded or re-rated items.RESULTS:Out of 2175 papers assessing psychomo…

medicine.medical_specialtyEmergency Medical ServicesConsensusPsychomotor agitationassessmentDelphi methodverbal de-escalation03 medical and health sciencesBenzodiazepines0302 clinical medicineMeta-Analysis as TopicRisk FactorsmedicineHumansPsychiatryPsychomotor AgitationBiological PsychiatryAgitation assessment psychiatric emergency restraint verbal de-escalationRandomized Controlled Trials as TopicPsychiatric Status Rating ScalesPsychiatryAgitationTask forceExpert consensusDisease ManagementEvidence-based medicinepsychiatric emergency3. Good health030227 psychiatryAgitation; assessment; psychiatric emergency; restraint; verbal de-escalation; Biological Psychiatry; Psychiatry and Mental HealthOlanzapinePsychiatry and Mental Healthrestraint[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthPractice Guidelines as TopicTreatment decision makingmedicine.symptomBiological psychiatryPsychology030217 neurology & neurosurgeryAntipsychotic Agents
researchProduct

1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00054/full En este artículo científico participan los siguientes autores: Mario Amore, Guido Di Sciascio, Radu Ioan Florea, Marina Garriga, Gabriel Gonzalez, Kai G. Kahl, Per-Axel Karlsson, Jens Kuhn, Maria Margariti, Bruno Pacciardi, Konstantinos Papageorgiou, Maurizio Pompili, Fabrice Rivollier, Ángel Royuela, Gemma Safont, Joachim Scharfetter, Bo Skagen, Kazuhiro Tajima-Pozo y Pierre Vidailhet. Agitation is a heterogeneous concept without a uniformly accepted definition, however, it is generally considered as a state of cognitive and motor hype…

Schizophrenia - Treatment.Psychomotor agitationlcsh:RC435-571media_common.quotation_subjectPsychomotor disorders - Treatment.ReviewMotor HyperactivityPsicosis maníaco depresiva - Tratamiento.Esquizofrenia - Farmacoterapia.Psicomotricidad - Trastornos - Tratamiento.03 medical and health sciences0302 clinical medicinePromotion (rank)Bipolar disorder Clinical practice Management Psychomotor agitation Schizophrenia Psychiatry and Mental HealthNursinglcsh:Psychiatrymedicinebipolar disorder; clinical practice; management; psychomotor agitation; schizophreniaManic-depressive illness030212 general & internal medicineManic-Depressive illness - Treatment.media_commonPsychiatrybipolar disorderProtocol (science)Psicosis maníaco depresiva - Farmacoterapia.Trastorn bipolarHealth professionalsCognitionManic-Depressive illnes - Chemotherapy.clinical practice030227 psychiatryschizophreniaClinical PracticeSchizophrenia - Chemotherapy.Psychiatry and Mental healthpsychomotor agitationSchizophreniaEsquizofrèniaEsquizofrenia - Tratamiento.medicine.symptomEmotional arousalPsychologymanagement
researchProduct